Breast Cancer Clinical Trial
Official title:
Breast MRI Screening in High-Risk Women After Mantle Radiation Therapy for Lymphoma
Objectives:
The objective of this single-arm, prospective study is to perform annual mammography and MRI
breast cancer screening in women who underwent mantle-field irradiation between 1970-1995 at
M. D. Anderson Cancer Center in order to compare the ability of MRI and standard mammography
to identify breast cancer. In addition, we will determine whether the combination of breast
MRI and mammography identifies smaller, earlier-stage tumors, which would lead to improved
cure rates. We will also take the opportunity to determine the incidence and stage of breast
cancer in this high-risk cohort.
Breast MRIs:
Breast MRIs have been reported to have higher sensitivity than mammograms for detecting
early breast cancers, particularly in dense breasts where mammograms are not as effective.
Although breast MRIs may add important information not provided by mammograms, the MRI must
be used selectively. This is because the MRI is very sensitive and may show a false positive
test (a test that shows cancer when there is none there).
Study Procedures:
If you are found to be eligible to take part in this study, the following procedures will be
performed 1 time a year.
- You will have a breast exam.
- You will have a mammogram. A mammogram is a breast x-ray used to detect breast cancer
and look for abnormalities in the breast.
- You will have an MRI of your breasts. For the MRI, you will lay on your stomach while a
large donut-shaped scanner takes images of your breasts.
If any abnormality is found, you will have routine follow-up procedures performed. Routine
follow-up may include additional imaging scans or biopsies. These will follow the standard
of care, and the information will be collected and stored in your medical record.
Length of Study:
You will be on study for 20 years, with annual check-ups with breast imaging studies at M.
D. Anderson. You will be taken off study if there is a change in your health that will not
allow a breast mammogram or MRI, such as becoming pregnant.
This is an investigational study.
Up to 223 patients will take part in this study. All will be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |